Ebola vaccines face daunting path to approval

Science

Volumn 349, Issue 6254, 2015, Pages 1272-1273

  Cohen, Jon ^a   Enserink, Martin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EBOLA VACCINE;

DRUG APPROVAL; DRUG EFFICACY; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG SAFETY; EBOLA HEMORRHAGIC FEVER; EPIDEMIC; GUINEA; HUMAN; LIBERIA; NONHUMAN; NOTE; PRIORITY JOURNAL; SIERRA LEONE; CLINICAL TRIAL (TOPIC); DISEASE OUTBREAKS; HEALTH CARE PLANNING; HEMORRHAGIC FEVER, EBOLA;

CLINICAL TRIALS AS TOPIC; DISEASE OUTBREAKS; DRUG APPROVAL; EBOLA VACCINES; GUINEA; HEMORRHAGIC FEVER, EBOLA; HUMANS; SIERRA LEONE; STRATEGIC STOCKPILE;

EID: 84942911775     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.349.6254.1272     Document Type: Note

References (0)